Are Analyst Price Targets Accurate? 7 Years of Data
How often Wall Street price targets are reached, how long it takes, and how the promised upside compares with what stocks actually did. From Exent’s backtest of 628,792 analyst ratings.
How often Jason Zemansky’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 891 ratings, compared with the average Wall Street analyst.
Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.
Jason Zemansky of Bank of America Securities ranks #854 of the 1,000 analysts Exent scores, with a 4.6★ rating and a focus on healthcare. Over a 7‑year lookback, 46.5% of Jason’s price targets were reached, 5.9 points below the 52.4% average across all analysts.
| Metric | Jason Zemansky | All analysts |
|---|---|---|
| Price‑target hit rate | 46.5% | 52.4% |
| Median days to hit target | 73 days | 91 days |
| Calls up after 12 months | 62.6% | 64.0% |
| Median 12‑month return of calls | +32.9% | +13.4% |
| Hit rate, last 2 years | 48.0% | — |
| Average worst drop after a call | −27.7% | — |
| Ratings in the sample | 891 | — |
| Stocks covered | 23 | — |
The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.
| Time to reach the target | Jason Zemansky |
|---|---|
| Under 30 days | 30.5% |
| 30–90 days | 25.4% |
| 90–180 days | 21.5% |
| Over 180 days | 22.6% |
Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.
| Stock | Ratings in the sample |
|---|---|
| KURA | 43 |
| CYTK | 38 |
| BBIO | 36 |
| INSM | 30 |
| TVTX | 28 |
| MDGL | 28 |
| BIIB | 27 |
| RCUS | 23 |
In the past year Jason’s ratings were 69% Buy, 28% Hold and 4% Sell.
| Date | Stock | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 17, 2026 | ABOS | Reiterated: Buy | Buy | $8.00 |
| Sep 15, 2026 | RCKT | Reiterated: Buy | Buy | $10.00 |
| Sep 8, 2026 | TYRA | Reiterated: Buy | Buy | $39.00 |
| Aug 31, 2026 | CYTK | Reiterated: Hold | Hold | $85.00 |
| Aug 14, 2026 | CYTK | Reiterated: Hold | Hold | $85.00 |
| Aug 13, 2026 | KURA | Reiterated: Buy | Buy | $31.00 |
| Aug 11, 2026 | TYRA | Reiterated: Buy | Buy | $39.00 |
| Aug 11, 2026 | LYEL | Reiterated: Sell | Sell | $12.00 |
| Aug 11, 2026 | RCUS | Reiterated: Hold | Hold | $29.00 |
| Aug 11, 2026 | KROS | Reiterated: Hold | Hold | $17.00 |
| Aug 11, 2026 | BBIO | Reiterated: Buy | Buy | $104.00 |
| Aug 7, 2026 | INSM | Reiterated: Buy | Buy | $214.00 |
Jason’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.
Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?
Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.
By Exent’s scoring Jason Zemansky ranks #854 of 1,000 with a 4.6★ rating. 46.5% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 62.6% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.
Jason Zemansky’s success rate is 46.4% by the ranking source and 46.5% by Exent’s price-target hit-rate backtest, with a median of 73 days to reach a target.
Jason Zemansky (Bank of America Securities) covers 23 stocks, mostly in healthcare. The most frequently rated are KURA, CYTK, BBIO, INSM, TVTX.
Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.